Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage

Personalized treatment strategies are crucial in managing lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved outcomes.
Stereotactic radiosurgery and whole-brain radiotherapy are evolving with novel systemic therapies, offering less invasive options.
Multidisciplinary approaches optimize treatment plans by considering genetic mutations, patient performance status, and metastatic disease extent.
Continuous research and clinical trials are essential for advancing management strategies and improving patient outcomes.

This article is sponsored by Azurity Pharmaceuticals, Inc.